119 related articles for article (PubMed ID: 38362848)
1. Comprehensive analysis of m
Li H; Li C; Zhang Y; Jiang W; Zhang F; Tang X; Sun G; Xu S; Dong X; Shou J; Yang Y; Chen M
Mol Carcinog; 2024 Apr; 63(4):677-687. PubMed ID: 38362848
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtypes of m
Guan B; Ren F; Shan W; Zhang S
Transl Cancer Res; 2022 Mar; 11(3):508-518. PubMed ID: 35402182
[TBL] [Abstract][Full Text] [Related]
3. m
Chen Y; Zhou C; Sun Y; He X; Xue D
Epigenomics; 2020 Jan; 12(2):87-99. PubMed ID: 31856595
[No Abstract] [Full Text] [Related]
4. Comprehensive Analysis of DNA 5-Methylcytosine and N6-Adenine Methylation by Nanopore Sequencing in Hepatocellular Carcinoma.
Zhang L; Rong W; Ma J; Li H; Tang X; Xu S; Wang L; Wan L; Zhu Q; Jiang B; Su F; Cui H
Front Cell Dev Biol; 2022; 10():827391. PubMed ID: 35321246
[TBL] [Abstract][Full Text] [Related]
5. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.
Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing.
Mao W; Yu Q; Wang K; Ma Q; Zheng Y; Zhang G; Luo W; Wang N; Wang Y
Front Oncol; 2022; 12():791332. PubMed ID: 35903698
[TBL] [Abstract][Full Text] [Related]
7. m
Zhong J; Liu Z; Cai C; Duan X; Deng T; Zeng G
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574053
[TBL] [Abstract][Full Text] [Related]
8. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
9. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway.
Miao D; Wang Q; Shi J; Lv Q; Tan D; Zhao C; Xiong Z; Zhang X
Cancer Commun (Lond); 2023 Apr; 43(4):480-502. PubMed ID: 36860124
[TBL] [Abstract][Full Text] [Related]
12. N
von Hagen F; Gundert L; Strick A; Klümper N; Schmidt D; Kristiansen G; Tolkach Y; Toma M; Ritter M; Ellinger J
Mol Carcinog; 2021 May; 60(5):354-362. PubMed ID: 33755994
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Evaluation of the m
Yu M; Liu X; Xu H; Shen S; Wang F; Chen D; Li G; Wang Z; Zuo Z; Zhao A
Front Immunol; 2022; 13():818120. PubMed ID: 35784363
[TBL] [Abstract][Full Text] [Related]
14. Profiling of circular RNA N
Wang Y; Wang H; Xi F; Wang H; Han X; Wei W; Zhang H; Zhang Q; Zheng Y; Zhu Q; Kohnen MV; Reddy ASN; Gu L
J Integr Plant Biol; 2020 Dec; 62(12):1823-1838. PubMed ID: 32735361
[TBL] [Abstract][Full Text] [Related]
15. Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma.
Fang Y; Chen G; Chen F; Hu E; Dong X; Li Z; He L; Sun Y; Qiu L; Xu H; Cai Z; Liu X
Cancer Sci; 2021 Sep; 112(9):3555-3568. PubMed ID: 34255396
[TBL] [Abstract][Full Text] [Related]
16. Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N
Zhang Y; Yao Y; Qi X; Li J; Liu M; Che X; Xu Y; Wu G
J Immunol Res; 2021; 2021():6617841. PubMed ID: 33628845
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the transcriptome-wide m
Han Z; Yang B; Wang Q; Hu Y; Wu Y; Tian Z
Cancer Cell Int; 2021 Mar; 21(1):142. PubMed ID: 33653351
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
19. The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1.
Shi Y; Dou Y; Zhang J; Qi J; Xin Z; Zhang M; Xiao Y; Ci W
Front Cell Dev Biol; 2021; 9():737498. PubMed ID: 34631715
[TBL] [Abstract][Full Text] [Related]
20. A Novel m
Chen S; Zhang N; Zhang E; Wang T; Jiang L; Wang X; Zheng J
Front Cell Dev Biol; 2020; 8():616972. PubMed ID: 33553151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
